Pfizer witnessed a dramatic 45.77% surge in trading volume, reaching a staggering 11.97 billion shares. Pfizer's stock price ...

Marlboro maker Philip Morris International missed second-quarter revenue expectations on Tuesday as shipments of its ZYN ...

Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...

Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

The purpose of investing in stocks is to make money, not lose it. So selling shares at a loss can be very upsetting. In this ...

The Bristol Myers Squibb-Pfizer Alliance today announced a new direct-to-patient option for purchasing Eliquis (apixaban) via ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

This comprehensive analysis delves into Pfizer’s current position, future prospects, and the factors shaping its stock outlook. Financial Performance and 2025 Guidance Pfizer’s financial performance ...

Financial Performance and 2025 Guidance Pfizer’s financial performance has shown resilience in the face of market uncertainties, generating revenue of $62.46 billion in the last twelve months.